Reata Pharmaceuticals (RETA) PT Raised to $230 at SVB Leerink
Tweet Send to a Friend
SVB Leerink analyst Joseph P. Schwartz raised the price target on Reata Pharmaceuticals (NASDAQ: RETA) to $230.00 (from $139.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
